UBS analyst Rory Smith upgraded Bodycote to Buy from Neutral with a price target of 860 GBp, up from 640 GBp. The company’s structural growth and margin expansion potential is being missed by the market, leading to an attractive share valuation, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BYPLF: